140 related articles for article (PubMed ID: 29845224)
1. Let‑7d inhibits colorectal cancer cell proliferation through the CST1/p65 pathway.
Jiang J; Liu HL; Tao L; Lin XY; Yang YD; Tan SW; Wu B
Int J Oncol; 2018 Aug; 53(2):781-790. PubMed ID: 29845224
[TBL] [Abstract][Full Text] [Related]
2. Identification of cystatin SN as a novel biomarker for pancreatic cancer.
Jiang J; Liu HL; Liu ZH; Tan SW; Wu B
Tumour Biol; 2015 May; 36(5):3903-10. PubMed ID: 25577248
[TBL] [Abstract][Full Text] [Related]
3. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer.
Oh BM; Lee SJ; Cho HJ; Park YS; Kim JT; Yoon SR; Lee SC; Lim JS; Kim BY; Choe YK; Lee HG
Cell Death Dis; 2017 Mar; 8(3):e2682. PubMed ID: 28300829
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer.
Choi EH; Kim JT; Kim JH; Kim SY; Song EY; Kim JW; Kim SY; Yeom YI; Kim IH; Lee HG
Clin Chim Acta; 2009 Aug; 406(1-2):45-51. PubMed ID: 19463800
[TBL] [Abstract][Full Text] [Related]
5. Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity.
Kim JT; Lee SJ; Kang MA; Park JE; Kim BY; Yoon DY; Yang Y; Lee CH; Yeom YI; Choe YK; Lee HG
Cell Death Dis; 2013 Dec; 4(12):e974. PubMed ID: 24357805
[TBL] [Abstract][Full Text] [Related]
6. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.
Dai DN; Li Y; Chen B; Du Y; Li SB; Lu SX; Zhao ZP; Zhou AJ; Xue N; Xia TL; Zeng MS; Zhong Q; Wei WD
J Mol Med (Berl); 2017 Aug; 95(8):873-886. PubMed ID: 28523467
[TBL] [Abstract][Full Text] [Related]
8. Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma.
Yang J; Luo G; Li C; Zhao Z; Ju S; Li Q; Chen Z; Ding C; Tong X; Zhao J
BMC Cancer; 2022 May; 22(1):589. PubMed ID: 35637432
[TBL] [Abstract][Full Text] [Related]
9. Extracellular cystatin SN and cathepsin B prevent cellular senescence by inhibiting abnormal glycogen accumulation.
Oh SS; Park S; Lee KW; Madhi H; Park SG; Lee HG; Cho YY; Yoo J; Dong Kim K
Cell Death Dis; 2017 Apr; 8(4):e2729. PubMed ID: 28383558
[TBL] [Abstract][Full Text] [Related]
10. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules.
Lai Y; Wang Y; Wu Y; Wu M; Xing S; Xie Y; Chen S; Li X; Zhang A; He Y; Li H; Dai S; Wang J; Lin S; Bai Y; Du H; Liu W
Cancer Control; 2022; 29():10732748221104661. PubMed ID: 35653624
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA 196B regulates FAS-mediated apoptosis in colorectal cancer cells.
Mo JS; Alam KJ; Kang IH; Park WC; Seo GS; Choi SC; Kim HS; Moon HB; Yun KJ; Chae SC
Oncotarget; 2015 Feb; 6(5):2843-55. PubMed ID: 25605245
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
16. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
[TBL] [Abstract][Full Text] [Related]
17. HOXC10 overexpression promotes cell proliferation and migration in gastric cancer.
Kim J; Bae DH; Kim JH; Song KS; Kim YS; Kim SY
Oncol Rep; 2019 Jul; 42(1):202-212. PubMed ID: 31115563
[TBL] [Abstract][Full Text] [Related]
18. miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2.
Li Q; Liang X; Wang Y; Meng X; Xu Y; Cai S; Wang Z; Liu J; Cai G
Sci Rep; 2016 May; 6():27157. PubMed ID: 27244080
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-518a-3p activates the NIK-dependent NF-κB pathway in colorectal cancer.
Qu LL; He L; Zhao X; Xu W
Int J Mol Med; 2015 May; 35(5):1266-72. PubMed ID: 25812680
[TBL] [Abstract][Full Text] [Related]
20. The miR-196b miRNA inhibits the GATA6 intestinal transcription factor and is upregulated in colon cancer patients.
Fantini S; Salsi V; Reggiani L; Maiorana A; Zappavigna V
Oncotarget; 2017 Jan; 8(3):4747-4759. PubMed ID: 27902469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
